GlassScriptPhysician profile
Todd Adam Gersten
NPI 1962408047
$33,277.14
in general payments reported to CMS, 2019-2025
100 companies · $5,529 in 2025
The $5,529 reported for 2025 was more than what 75% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,811 · 2020: $3,902 · 2021: $3,965 · 2022: $4,614 · 2023: $5,196 · 2024: $5,260 · 2025: $5,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Long Term Medical Supply Or Device Loan: $299 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,533.35 |
| Long Term Medical Supply Or Device Loan | $299.10 |
| Education | $153.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,073.23 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,935.47 | 2019-2025 | Kisqali, Piqray |
| Janssen Biotech, INC. | $1,700.50 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astrazeneca Pharmaceuticals LP | $1,700.30 | 2019-2025 | Tagrisso, Enhertu, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $1,616.93 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,538.41 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Celgene Corporation | $1,504.18 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $1,443.88 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Glaxosmithkline, LLC. | $1,344.86 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Genzyme Corporation | $1,202.74 | 2019-2025 | |
| Seagen INC. | $1,029.36 | 2019-2023 | Tukysa, Padcev, Tivdak |
| Genentech USA, INC. | $1,021.10 | 2019-2025 | Tecentriq, Phesgo, Polivy |
| Incyte Corporation | $935.55 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Astellas Pharma US INC | $926.85 | 2019-2025 | Xtandi, Padcev, Vyloy |
| Amgen INC. | $901.46 | 2019-2023 | Nplate, Vectibix, Kyprolis |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $849.29 | 2019-2025 | |
| Daiichi Sankyo INC. | $808.37 | 2019-2025 | Enhertu, Datroway |
| Lilly USA, LLC | $770.98 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Eisai INC. | $729.62 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $666.55 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Blueprint Medicines Corporation | $465.01 | 2020-2025 | Ayvakit |
| Ipsen Biopharmaceuticals, INC | $397.28 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Janssen Scientific Affairs, LLC | $350.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $338.32 | 2019-2025 | Libtayo |
| Rigel Pharmaceuticals, INC. | $323.12 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Alexion Pharmaceuticals, INC. | $298.11 | 2019-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $295.83 | 2019-2025 | Zepzelca |
| Puma Biotechnology, INC. | $271.78 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.05 | 2019-2025 | |
| Adaptive Biotechnologies Corporation | $241.08 | 2022-2025 | Clonoseq |
| Kite Pharma, INC. | $235.68 | 2020-2025 | Yescarta |
| Foundation Medicine, INC. | $235.52 | 2019-2021 | |
| Pharmacyclics LLC, An Abbvie Company | $232.96 | 2019-2023 | Imbruvica, Epkinly |
| Exelixis INC. | $226.47 | 2022-2025 | Cabometyx |
| Emd Serono, INC. | $223.35 | 2022-2025 | Bavencio, Tepmetko |
| Array Biopharma INC | $208.47 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Dova Pharmaceuticals | $200.63 | 2019-2021 | |
| Sobi, INC | $200.27 | 2022-2024 | |
| Taiho Oncology, INC. | $170.29 | 2020-2025 | |
| Aveo Pharmaceuticals, INC. | $169.99 | 2022-2024 | Fotivda |
| Beigene USA, INC. | $149.63 | 2022-2025 | Brukinsa, Tevimbra |
| Clovis Oncology, INC. | $147.18 | 2019-2022 | |
| Servier Pharmaceuticals LLC | $145.81 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $142.76 | 2021-2025 | Precisetumor, Myrisk |
| Dendreon Pharmaceuticals LLC | $142.69 | 2019-2025 | Provenge |
| Aurobindo Pharma USA, INC. | $126.68 | 2019-2020 | |
| Gilead Sciences, INC. | $125.39 | 2019-2023 | |
| Legend Biotech USA INC. | $121.55 | 2024-2025 | Carvykti |
| Karyopharm Therapeutics INC. | $118.97 | 2021-2025 | Xpovio |
| Deciphera Pharmaceuticals INC. | $117.06 | 2023-2025 | Qinlock, Romvimza, Tgct |
| Morphosys, US INC. | $102.61 | 2021-2022 | |
| Sirtex Medical INC | $98.83 | 2019-2023 | Sir-Spheres Microspheres |
| Menarini Silicon Biosystems, INC. | $97.50 | 2024 | |
| Agios Pharmaceuticals, INC. | $92.15 | 2019-2025 | Pyrukynd |
| Genmab U.S., INC. | $90.21 | 2024-2025 | Epkinly |
| Kyowa Kirin, INC. | $82.19 | 2021-2023 | Poteligeo |
| Tersera Therapeutics LLC | $78.76 | 2022-2025 | Zoladex |
| Mirati Therapeutics, INC. | $71.86 | 2023-2024 | Krazati |
| Sun Pharmaceutical Industries INC. | $64.69 | 2021-2024 | |
| Tesaro, INC. | $63.94 | 2019 | |
| Shield Therapeutics INC | $59.17 | 2023 | Accrufer |
| Heron Therapeutics, INC. | $56.74 | 2019-2022 | |
| Pharmaessentia USA Corporation | $54.81 | 2022-2025 | Besremi |
| Beone Medicines USA, INC. | $50.76 | 2025 | Brukinsa |
| Pharmacosmos Therapeutics INC. | $49.43 | 2023-2024 | Monoferric |
| Stemline Therapeutics INC. | $48.45 | 2025 | Orserdu |
| Geron Corporation | $41.44 | 2025 | Rytelo |
| Cti Biopharma Corp. | $40.85 | 2023 | Vonjo |
| G1 Therapeutics, INC. | $38.79 | 2022 | |
| Acceleron Pharma, INC. | $37.71 | 2020 | |
| Medtronic, INC. | $37.44 | 2022 | |
| Sanofi-Aventis U.S. LLC | $36.56 | 2019-2021 | |
| Blue Earth Diagnostics | $32.18 | 2024 | |
| Helsinn Therapeutics (U.S.), INC. | $31.84 | 2019 | |
| Verastem, INC. | $31.30 | 2019-2020 | |
| Napo Pharmaceuticals INC | $29.37 | 2024 | Gelclair Concentrated Oral Gel |
| Iovance Biotherapeutics, INC. | $26.57 | 2025 | Amtagvi |
| Lexicon Pharmaceuticals, INC. | $25.05 | 2019-2020 | |
| Secura Bio, INC. | $23.98 | 2020 | |
| Springworks Therapeutics, INC. | $23.30 | 2025 | Ogsiveo |
| Coherus Oncology, INC. | $23.01 | 2022 | |
| Nuvation Bio INC. | $22.24 | 2025 | Ibtrozi |
| Azurity Pharmaceuticals, INC. | $21.05 | 2025 | Danziten |
| Partner Therapeutics, INC. | $20.09 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $20.07 | 2023 | Sancuso |
| Immunocore Limited | $19.94 | 2024 | Kimmtrak |
| Adc Therapeutics America, INC. | $19.61 | 2024 | |
| Immunogen, INC. | $18.90 | 2023 | Elahere |
| Novocure INC. | $18.30 | 2025 | Optune Lua (Novottf-200t) |
| Shire North American Group INC | $18.11 | 2019 | |
| Tg Therapeutics, INC. | $17.49 | 2021 | |
| Emmaus Medical, INC. | $16.14 | 2019 | |
| Global Blood Therapeutics, INC. | $16.07 | 2021 | |
| Eusa Pharma (US) LLC | $15.50 | 2021 | |
| Advanced Accelerator Applications | $11.26 | 2019 | |
| Veracyte, INC. | $6.32 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
Keytruda $832Enhertu $699Xtandi $559Reblozyl $550Jakafi $478Sarclisa $451Kisqali $392Lynparza $389Venclexta $389Padcev $354Tukysa $352Talzenna $349Jemperli $324Zejula $321Erleada $311Rezlidhia $307Tavalisse $307Pomalyst $304Lenvima $300Orgovyx $293Ibrance $276Carvykti $272Tagrisso $255Opdivo $254Tecentriq $251Pluvicto $236Rybrevant $231Ojjaara $218Jaypirca $217Cabometyx $215Libtayo $213Welireg $201Epkinly $198Elrexfio $190Opdualag $182Verzenio $181Imbruvica $180Onivyde $180Clonoseq $180Piqray $169Nubeqa $162Lorbrena $153Fruzaqla $149Krazati $149Lutathera $148Ultomiris $147Fotivda $147Elahere $141Inlyta $138Brukinsa $137Braftovi $130Mektovi $130Zepzelca $128Talvey $128Gavreto $125Tivdak $121Phesgo $120Qinlock $117Adcetris $116Xofigo $113Vyloy $111Datroway $104Darzalex $104Cellsearch $97.50Yescarta $94.60Vonjo $94.11Scemblix $93.13Provenge $91.20Inqovi $90.43Lonsurf $90.43Bosulif $90.37Vitrakvi $89.11Stivarga $89.11Xpovio $87.30Alunbrig $81.70Somatuline Depot $81.41Retevmo $81.27Tecvayli $78.29Enjaymo $76.47Ayvakit $75.14Doptelet $73.81Akeega $66.30Nerlynx $64.95Bavencio $63.02Ninlaro $61.81Jevtana $61.06Zoladex $60.88Iclusig $59.53Accrufer $59.17Cablivi $57.88Romvimza $54.99Vonvendi $52.71Tibsovo $49.68Monoferric $49.43Orserdu $48.45Tazverik $42.37Rytelo $41.44Augtyro $41.40Precisetumor $40.92Vectibix $37.93
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Gersten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.